These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
ASSOCIATED CAPITAL GROUP, INC.
|
|
(Exact name of Registrant as specified in its charter)
|
|
Delaware
|
47-3965991
|
|
|
(State of other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
140 Greenwich Avenue, Greenwich, CT
One Corporate Center, Rye, NY
|
06830
10580-1422
|
|
|
(Address of principle executive offices)
|
(Zip Code)
|
|
(203) 629-9595
|
|
(Registrant’s telephone number, including area code)
|
|
Large accelerated filer ☐
|
Accelerated filer ☒
|
|
|
Non-accelerated filer ☐
|
Smaller reporting company ☒
|
Emerging growth company ☒
|
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
|
Class A Common Stock, par value $0.001 per share
|
AC
|
New York Stock Exchange
|
|
Class
|
Outstanding at April 30, 2019
|
|
|
Class A Common Stock, .001 par value
|
3,531,034
|
|
|
Class B Common Stock, .001 par value
|
19,022,918
|
|
PART I.
|
FINANCIAL INFORMATION
|
|
|
Item 1.
|
1 | |
|
Item 2.
|
22 | |
|
Item 3.
|
27 | |
|
Item 4.
|
27 | |
|
PART II.
|
OTHER INFORMATION
|
|
|
Item 1.
|
28
|
|
|
Item 2.
|
28
|
|
|
Item 6.
|
29
|
|
|
30
|
|
March 31,
2019
|
December 31,
2018
|
|||||||
|
ASSETS
|
||||||||
|
Cash and cash equivalents
|
$
|
396,020
|
$
|
409,564
|
||||
|
Investments in securities
|
219,104
|
179,011
|
||||||
|
Investment in GBL stock (3,016,501 shares)
|
61,838
|
50,949
|
||||||
|
Investments in affiliated registered investment companies
|
150,563
|
142,135
|
||||||
|
Investments in partnerships
|
126,139
|
118,729
|
||||||
|
Receivable from brokers
|
26,980
|
24,629
|
||||||
|
Investment advisory fees receivable
|
1,188
|
4,394
|
||||||
|
Receivable from affiliates
|
731
|
1,309
|
||||||
|
Deferred tax assets, net
|
6,871
|
9,422
|
||||||
|
Goodwill and intangible assets
|
3,519
|
3,519
|
||||||
|
Other assets
|
1,743
|
10,772
|
||||||
|
Total assets
|
$
|
994,696
|
$
|
954,433
|
||||
|
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY
|
||||||||
|
Payable to brokers
|
$
|
17,423
|
$
|
5,511
|
||||
|
Income taxes payable
|
7,222
|
3,577
|
||||||
|
Compensation payable
|
7,511
|
11,388
|
||||||
|
Securities sold, not yet purchased
|
17,118
|
9,574
|
||||||
|
Payable to affiliates
|
1,135
|
515
|
||||||
|
Accrued expenses and other liabilities
|
4,502
|
7,820
|
||||||
|
Total liabilities
|
54,911
|
38,385
|
||||||
|
Redeemable noncontrolling interests
|
50,781
|
49,800
|
||||||
|
Equity:
|
||||||||
|
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued and outstanding
|
-
|
-
|
||||||
|
Class A Common Stock, $0.001 par value; 100,000,000 shares authorized; 6,569,254 and 6,537,768
shares issued, respectively; 3,552,462 and 3,530,752 shares outstanding, respectively
|
6
|
6
|
||||||
|
Class B Common Stock, $0.001 par value; 100,000,000 shares authorized; 19,196,792 shares issued;
19,022,918 and 19,054,404 shares outstanding, respectively
|
19
|
19
|
||||||
|
Additional paid-in capital
|
1,008,319
|
1,008,319
|
||||||
|
Accumulated deficit
|
(16,742
|
)
|
(39,889
|
)
|
||||
|
Treasury stock, at cost (3,016,792 and 3,007,016 shares, respectively)
|
(102,598
|
)
|
(102,207
|
)
|
||||
|
Total Associated Capital Group, Inc. stockholders’ equity
|
889,004
|
866,248
|
||||||
|
Total liabilities and equity
|
$
|
994,696
|
$
|
954,433
|
||||
|
Three Months Ended
March 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Revenues
|
||||||||
|
Investment advisory and incentive fees
|
$
|
2,733
|
$
|
2,529
|
||||
|
Institutional research services
|
1,913
|
2,152
|
||||||
|
Other
|
6
|
22
|
||||||
|
Total revenues
|
4,652
|
4,703
|
||||||
|
Expenses
|
||||||||
|
Compensation
|
6,311
|
6,396
|
||||||
|
Management fee
|
3,260
|
-
|
||||||
|
Other operating expenses
|
2,957
|
2,557
|
||||||
|
Total expenses
|
12,528
|
8,953
|
||||||
|
Operating loss
|
(7,876
|
)
|
(4,250
|
)
|
||||
|
Other income (expense)
|
||||||||
|
Net gain/(loss) from investments
|
34,979
|
(27,530
|
)
|
|||||
|
Interest and dividend income
|
3,786
|
2,707
|
||||||
|
Interest expense
|
(44
|
)
|
(33
|
)
|
||||
|
Total other income (expense), net
|
38,721
|
(24,856
|
)
|
|||||
|
Income/(loss) before income taxes
|
30,845
|
(29,106
|
)
|
|||||
|
Income tax expense/(benefit)
|
6,191
|
(6,734
|
)
|
|||||
|
Net income/(loss)
|
24,654
|
(22,372
|
)
|
|||||
|
Net income/(loss) attributable to noncontrolling interests
|
1,507
|
(143
|
)
|
|||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
23,147
|
$
|
(22,229
|
)
|
|||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
per share:
|
||||||||
|
Basic
|
$
|
1.02
|
$
|
(0.95
|
)
|
|||
|
Diluted
|
$
|
1.02
|
$
|
(0.95
|
)
|
|||
|
Weighted average shares outstanding:
|
||||||||
|
Basic
|
22,584
|
23,508
|
||||||
|
Diluted
|
22,584
|
23,508
|
||||||
|
Three Months Ended
March 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Net income/(loss)
|
$
|
24,654
|
$
|
(22,372
|
)
|
|||
|
Less: Comprehensive income/(loss) attributable to noncontrolling interests
|
1,507
|
(143
|
)
|
|||||
|
Comprehensive income/(loss) attributable to Associated Capital Group, Inc.
|
$
|
23,147
|
$
|
(22,229
|
)
|
|||
|
Associated Capital Group, Inc. shareholders
|
||||||||||||||||||||||||
|
Common
Stock
|
Accumulated
Deficit
|
Additional
Paid-in
|
Treasury
Stock
|
Total
|
Redeemable
Noncontrolling
|
|||||||||||||||||||
|
Balance at December 31, 2018
|
$
|
25
|
$
|
(39,889
|
)
|
$
|
1,008,319
|
$
|
(102,207
|
)
|
$
|
866,248
|
$
|
49,800
|
||||||||||
|
Redemptions of
noncontrolling interests
|
-
|
-
|
-
|
-
|
-
|
(526
|
)
|
|||||||||||||||||
|
Net income
|
-
|
23,147
|
-
|
-
|
23,147
|
1,507
|
||||||||||||||||||
|
Purchase of treasury stock
|
-
|
-
|
-
|
(391
|
)
|
(391
|
)
|
-
|
||||||||||||||||
|
Balance at March 31, 2019
|
$
|
25
|
$
|
(16,742
|
)
|
$
|
1,008,319
|
$
|
(102,598
|
)
|
$
|
889,004
|
$
|
50,781
|
||||||||||
|
Associated Capital Group, Inc. shareholders
|
||||||||||||||||||||||||||||||||
|
Common
Stock
|
Retained
Earnings/
|
Additional
Paid-in
|
GBL 4%
PIK Note
|
Accumulated
Comprehensive
|
Treasury
Stock
|
Total
|
Redeemable
Noncontrolling
|
|||||||||||||||||||||||||
|
Balance at December 31, 2017
|
$
|
25
|
$
|
13,800
|
$
|
1,010,505
|
$
|
(50,000
|
)
|
$
|
6,712
|
$
|
(62,895
|
)
|
$
|
918,147
|
$
|
46,230
|
||||||||||||||
|
Reclassifications pursuant to
adoption of new accounting guidance
|
-
|
6,712
|
-
|
-
|
(6,712
|
)
|
-
|
-
|
-
|
|||||||||||||||||||||||
|
Redemptions of
noncontrolling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,971
|
)
|
|||||||||||||||||||||||
|
Consolidation of certain
investment funds
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
6,488
|
||||||||||||||||||||||||
|
Net loss
|
-
|
(22,229
|
)
|
-
|
-
|
-
|
-
|
(22,229
|
)
|
(143
|
)
|
|||||||||||||||||||||
|
Stock-based compensation expense
|
-
|
-
|
72
|
-
|
-
|
-
|
72
|
-
|
||||||||||||||||||||||||
|
Proceeds from payment of
GAMCO Note
|
-
|
-
|
-
|
10,000
|
-
|
-
|
10,000
|
-
|
||||||||||||||||||||||||
|
Exchange offer
|
-
|
-
|
-
|
-
|
-
|
(17,737
|
)
|
(17,737
|
)
|
-
|
||||||||||||||||||||||
|
Purchase of treasury stock
|
-
|
-
|
-
|
-
|
-
|
(459
|
)
|
(459
|
)
|
-
|
||||||||||||||||||||||
|
Balance at March 31, 2018
|
$
|
25
|
$
|
(1,717
|
)
|
$
|
1,010,577
|
$
|
(40,000
|
)
|
$
|
-
|
$
|
(81,091
|
)
|
$
|
887,794
|
$
|
50,604
|
|||||||||||||
|
Three Months Ended
March 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Operating activities
|
||||||||
|
Net income (loss)
|
$
|
24,654
|
$
|
(22,372
|
)
|
|||
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
||||||||
|
Equity in net (gains) losses from partnerships
|
(3,838
|
)
|
499
|
|||||
|
Depreciation and amortization
|
6
|
4
|
||||||
|
Stock-based compensation expense
|
-
|
72
|
||||||
|
Loss on exchange offer
|
-
|
2,127
|
||||||
|
Donated securities
|
944
|
-
|
||||||
|
Unrealized gains on securities
|
(20,107
|
)
|
-
|
|||||
|
Realized losses on sales of securities
|
60
|
-
|
||||||
|
(Increase) decrease in assets:
|
||||||||
|
Investments in securities
|
(35,098
|
)
|
(14,225
|
)
|
||||
|
Investments in partnerships:
|
||||||||
|
Contributions to partnerships
|
(4,071
|
)
|
(2,977
|
)
|
||||
|
Distributions from partnerships
|
500
|
1,916
|
||||||
|
Receivable from affiliates
|
578
|
(369
|
)
|
|||||
|
Receivable from brokers
|
(2,351
|
)
|
19,523
|
|||||
|
Investment advisory fees receivable
|
3,206
|
4,254
|
||||||
|
Income taxes receivable and deferred tax assets, net
|
2,551
|
(1,241
|
)
|
|||||
|
Other assets
|
9,021
|
6,356
|
||||||
|
Increase (decrease) in liabilities:
|
||||||||
|
Payable to brokers
|
11,912
|
(7,660
|
)
|
|||||
|
Income taxes payable and deferred tax liabilities, net
|
3,645
|
(5,484
|
)
|
|||||
|
Payable to affiliates
|
620
|
40
|
||||||
|
Compensation payable
|
(3,877
|
)
|
(9,803
|
)
|
||||
|
Accrued expenses and other liabilities
|
(1,060
|
)
|
(48
|
)
|
||||
|
Total adjustments
|
(37,359
|
)
|
(7,016
|
)
|
||||
|
Net cash used in operating activities
|
$
|
(12,705
|
)
|
$
|
(29,388
|
)
|
||
|
Three Months Ended
March 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Investing activities
|
||||||||
|
Purchases of securities
|
$
|
(342
|
)
|
$
|
-
|
|||
|
Proceeds from sales of securities
|
2,108
|
-
|
||||||
|
Return of capital on securities
|
571
|
-
|
||||||
|
Proceeds from note receivable
|
-
|
15,000
|
||||||
|
Net cash provided by investing activities
|
2,337
|
15,000
|
||||||
|
Financing activities
|
||||||||
|
Redemptions of redeemable noncontrolling interests
|
(526
|
)
|
(1,971
|
)
|
||||
|
Dividends paid
|
(2,259
|
)
|
(2,369
|
)
|
||||
|
Purchase of treasury stock
|
(391
|
)
|
(459
|
)
|
||||
|
Proceeds from payment of GBL 4% PIK Note
|
-
|
10,000
|
||||||
|
Net cash (used in) provided by financing activities
|
(3,176
|
)
|
5,201
|
|||||
|
Net decrease in cash and cash equivalents
|
(13,544
|
)
|
(9,187
|
)
|
||||
|
Cash and cash equivalents at beginning of period
|
409,764
|
293,312
|
||||||
|
Increase in cash from consolidation
|
-
|
47
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
396,220
|
$
|
284,172
|
||||
|
Supplemental disclosures of cash flow information:
|
||||||||
|
Cash paid for interest
|
$
|
44
|
$
|
33
|
||||
|
Cash paid for taxes
|
$
|
-
|
$
|
-
|
||||
|
Reconciliation to cash, cash equivalents and restricted cash
|
||||||||
|
Cash and cash equivalents
|
396,020
|
283,972
|
||||||
|
Restricted cash included in receivable from brokers
|
200
|
200
|
||||||
|
Cash, cash equivalents and restricted cash
|
$
|
396,220
|
$
|
284,172
|
||||
|
Non-cash activity:
|
||
|
|
- | On January 1, 2018, AC was deemed to have control over certain investment funds which resulted in their consolidation and an increase of approximately $47 of cash and cash equivalents, $6,441 of net assets and an increase of approximately $6,488 of redeemable noncontrolling interests. |
|
|
- | During the first quarter of 2018, AC completed an exchange offer with respect to its Class A shares. The Company exchanged 666,805 GBL Class A shares valued at $17,737 for 493,954 Class A shares. |
|
A.
|
Basis of Presentation and Significant Accounting Policies
|
|
B.
|
Revenue
|
|
|
a. |
Asset-based advisory fees – The Company receives a management fee, payable monthly in advance based on value of the net assets of the client. It is generally set at a rate
of 1%-1.5% per annum. Asset-based management fee revenue is recognized only as the services are performed over the period.
|
|
|
b. |
Performance-based advisory fees – Certain client contracts call for additional fees and or allocations of income tied to a certain percentage, generally 20%, of the
investment performance of the account over a measurement period, typically the calendar year. In addition, the contracts provide that performance-based fees or allocations become fixed in the event of an investor redemption prior to the
end of the measurement period. In the event that an account suffers a loss in one period, it must be recovered before incentive fees are earned by the Company; this is commonly referred to as a “high water mark” provision. While the
Company’s performance obligation is satisfied over time, the Company does not recognize performance-based fees until the end of the measurement period or the time of the investor redemption when the uncertainty surrounding the amount of
the variable consideration is resolved.
|
|
|
c. |
Sub-advisory fees – Pursuant to agreements with other investment advisors, the Company receives a percentage of advisory fees received by such advisors from certain of
their investment fund clients. These fees may be either asset- or performance-based. In addition, they may be subject to reduction by certain expenses as set forth in the respective agreements. Sub-advisory fee revenue which is
asset-based is recognized ratably as the services are performed over the relevant contractual performance period. Sub-advisory fee revenue which is performance-based is recognized only when it becomes fixed and not subject to
adjustment.
|
|
|
a. |
Hard dollar payments – The Company receives direct payments for research services provided to related and unrelated parties. The Company may or may not have contracts for
such services. Where a contract for such services is in place, the contractual fee for the period is recognized ratably over the contract period, typically a calendar year, which is considered the period over which the Company satisfies
its performance obligation. Payments for contracts with affiliated parties are collected monthly. For other payments where no research contract exists, revenue is not recognized until agreement is reached with the client that the
Company has satisfied its performance obligation. At that time, a value is assigned to those services and an invoice is presented to the client for payment.
|
|
|
b. |
Commissions – Commissions are charged on the execution of securities transactions made on behalf of client accounts on an agency basis and are based on a rate schedule. The
Company meets its performance obligations and recognizes commission revenue when the related securities transactions are executed and the security is transferred to or from the customer. Commissions earned are typically collected from
the clearing brokers utilized by G.research on a daily or weekly basis.
|
|
|
c. |
Selling concessions – The Company participates as a member of the selling group of underwritten equity offerings and receives compensation based on the difference between
what its clients pay for the securities sold to its institutional clients and what the issuer receives. The terms of the selling concessions are set forth in contracts between the Company and the underwriter. The Company meets its
performance obligations and recognizes selling commissions upon the sale of the related securities to its clients.
|
|
|
d. |
Sales manager fees – The Company participates as sales manager of at-the-market offerings of certain affiliated closed-end funds and receives a tiered percentage of
proceeds as stipulated in agreements between the Company, the funds and the funds’ investment adviser and as approved by the funds’ board of directors. The Company meets its performance obligations and recognizes sales manager fees upon
sale of the related closed-end funds. Sales manager fees earned are typically collected from the clearing brokers utilized by G.research on a daily or weekly basis.
|
|
Three months ended March 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Investment advisory and incentive fees
|
||||||||
|
Asset-based advisory fees
|
$
|
1,724
|
$
|
1,839
|
||||
|
Performance-based advisory fees
|
13
|
7
|
||||||
|
Sub-advisory fees
|
996
|
683
|
||||||
|
2,733
|
2,529
|
|||||||
|
Institutional research services
|
||||||||
|
Hard dollar payments
|
487
|
930
|
||||||
|
Commissions
|
1,426
|
1,196
|
||||||
|
Selling concessions
|
-
|
26
|
||||||
|
1,913
|
2,152
|
|||||||
|
Other
|
||||||||
|
Underwriting fees
|
-
|
19
|
||||||
|
Miscellaneous
|
6
|
3
|
||||||
|
6
|
22
|
|||||||
|
Total
|
$
|
4,652
|
$
|
4,703
|
||||
|
C.
|
Investment in Securities
|
|
March 31, 2019
|
December 31, 2018
|
|||||||||||||||
|
Cost
|
Fair Value
|
Cost
|
Fair Value
|
|||||||||||||
|
Government obligations
|
$
|
28,489
|
$
|
28,648
|
$
|
11,694
|
$
|
11,707
|
||||||||
|
Common stocks
|
258,470
|
247,485
|
244,557
|
213,151
|
||||||||||||
|
Mutual funds
|
762
|
1,332
|
761
|
1,161
|
||||||||||||
|
Other investments
|
5,284
|
3,477
|
5,285
|
3,941
|
||||||||||||
|
Total investments in securities
|
$
|
293,005
|
$
|
280,942
|
$
|
262,297
|
$
|
229,960
|
||||||||
|
March 31, 2019
|
December 31, 2018
|
|||||||||||||||
|
Proceeds
|
Fair Value
|
Proceeds
|
Fair Value
|
|||||||||||||
|
Common stocks
|
$
|
16,393
|
$
|
17,011
|
$
|
10,150
|
$
|
9,485
|
||||||||
|
Other investments
|
-
|
107
|
-
|
89
|
||||||||||||
|
Total securities sold, not yet purchased
|
$
|
16,393
|
$
|
17,118
|
$
|
10,150
|
$
|
9,574
|
||||||||
|
March 31, 2019
|
December 31, 2018
|
|||||||||||||||
|
Cost
|
Fair Value
|
Cost
|
Fair Value
|
|||||||||||||
|
Closed-end funds
|
$
|
73,717
|
$
|
93,434
|
$
|
73,950
|
$
|
85,090
|
||||||||
|
Mutual funds
|
47,550
|
57,129
|
49,714
|
57,045
|
||||||||||||
|
Total investments in affiliated
registered investment companies
|
$
|
121,267
|
$
|
150,563
|
$
|
123,664
|
$
|
142,135
|
||||||||
|
|
Asset Derivatives
|
Liability Derivatives
|
||||||||||||||||
|
|
Statement of
Financial Condition
Location
|
Fair Value
|
Statement of
Financial Condition
Location
|
Fair Value
|
||||||||||||||
|
March 31,
2019
|
December 31,
2018
|
March 31,
2019
|
December 31,
2018
|
|||||||||||||||
|
Derivatives designated as hedging
|
||||||||||||||||||
|
instruments under FASB ASC 815-20
|
||||||||||||||||||
|
Foreign exchange contracts
|
Receivable from brokers
|
$
|
285
|
$
|
204
|
Payable to brokers
|
$
|
-
|
$
|
-
|
||||||||
|
Derivatives not designated as hedging
|
||||||||||||||||||
|
instruments under FASB ASC 815-20
|
||||||||||||||||||
|
Equity contracts
|
Investments in
securities
|
$
|
145
|
$
|
464
|
Securities sold,
not yet purchased
|
$
|
107
|
$
|
89
|
||||||||
|
Total derivatives
|
$
|
430
|
$
|
668
|
$
|
107
|
$
|
89
|
||||||||||
|
Type of Derivative
|
Income Statement Location
|
Three Months ended March 31,
|
||||||||
|
2019
|
2018
|
|||||||||
|
Foreign exchange contracts
|
Net gain/(loss) from investments
|
$
|
81
|
$
|
-
|
|||||
|
Equity contracts
|
Net gain/(loss) from investments
|
(2,022
|
)
|
1,778
|
||||||
|
Total
|
$
|
(1,941
|
)
|
$
|
1,778
|
|||||
|
Gross
Amounts of
|
Gross Amounts
Offset in the
|
Net Amounts of
Assets Presented
|
Gross Amounts Not Offset in the
Statements of Financial Condition
|
|||||||||||||||||||||
|
Financial
Instruments
|
Cash Collateral
Received
|
Net Amount
|
||||||||||||||||||||||
|
Swaps:
|
(In thousands)
|
|||||||||||||||||||||||
|
March 31, 2019
|
$
|
70
|
$
|
-
|
$
|
70
|
$
|
(70
|
)
|
$
|
-
|
$
|
-
|
|||||||||||
|
December 31, 2018
|
416
|
-
|
416
|
(89
|
)
|
-
|
327
|
|||||||||||||||||
|
Gross
Amounts of
Recognized
Liabilities
|
|
|
Gross Amounts
Offset in the
Statements of
Financial Condition
|
|
|
Net Amounts of
Liabilities Presented
in the Statements
of Financial Condition
|
|
|
Gross Amounts Not Offset in the
Statements of Financial Condition
|
|||||||||||||||
|
Financial
Instruments
|
|
|
Cash Collateral
Pledged
|
|
Net Amount
|
|
||||||||||||||||||
|
Swaps:
|
(In thousands)
|
|||||||||||||||||||||||
|
March 31, 2019
|
$
|
106
|
$
|
-
|
$
|
106
|
$
|
(70
|
)
|
$
|
-
|
$
|
36
|
|||||||||||
|
December 31, 2018
|
89
|
-
|
89
|
(89
|
)
|
-
|
-
|
|||||||||||||||||
|
D.
|
Investment Partnerships and Variable Interest Entities
|
|
VIEs
|
VOEs
|
|||||||
|
Entities consolidated at December 31, 2017
|
1
|
3
|
||||||
|
Additional consolidated entities
|
-
|
2
|
||||||
|
Deconsolidated entities
|
-
|
-
|
||||||
|
Entities consolidated at March 31, 2018
|
1
|
5
|
||||||
|
Additional consolidated entities
|
-
|
-
|
||||||
|
Deconsolidated entities
|
-
|
-
|
||||||
|
Entities consolidated at December 31, 2018
|
1
|
5
|
||||||
|
Additional consolidated entities
|
-
|
-
|
||||||
|
Deconsolidated entities
|
-
|
-
|
||||||
|
Entities consolidated at March 31, 2019
|
1
|
5
|
||||||
|
March 31, 2019
|
||||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Assets
|
||||||||||||
|
Cash and cash equivalents
|
$
|
377,343
|
$
|
18,677
|
$
|
396,020
|
||||||
|
Investments in securities (including GBL stock)
|
171,339
|
109,603
|
280,942
|
|||||||||
|
Investments in affiliated investment companies
|
202,066
|
(51,503
|
)
|
150,563
|
||||||||
|
Investments in partnerships
|
146,256
|
(20,117
|
)
|
126,139
|
||||||||
|
Receivable from brokers
|
4,992
|
21,988
|
26,980
|
|||||||||
|
Investment advisory fees receivable
|
1,212
|
(24
|
)
|
1,188
|
||||||||
|
Other assets
|
12,437
|
427
|
12,864
|
|||||||||
|
Total assets
|
$
|
915,645
|
$
|
79,051
|
$
|
994,696
|
||||||
|
Liabilities and equity
|
||||||||||||
|
Securities sold, not yet purchased
|
$
|
5,920
|
$
|
11,198
|
$
|
17,118
|
||||||
|
Accrued expenses and other liabilities
|
20,721
|
17,072
|
37,793
|
|||||||||
|
Redeemable noncontrolling interests
|
-
|
50,781
|
50,781
|
|||||||||
|
Total equity
|
889,004
|
-
|
889,004
|
|||||||||
|
Total liabilities and equity
|
$
|
915,645
|
$
|
79,051
|
$
|
994,696
|
||||||
|
December 31, 2018
|
||||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Assets
|
||||||||||||
|
Cash and cash equivalents
|
$
|
396,074
|
$
|
13,490
|
$
|
409,564
|
||||||
|
Investments in securities (including GBL stock)
|
131,764
|
98,196
|
229,960
|
|||||||||
|
Investments in affiliated investment companies
|
193,006
|
(50,871
|
)
|
142,135
|
||||||||
|
Investments in partnerships
|
138,119
|
(19,390
|
)
|
118,729
|
||||||||
|
Receivable from brokers
|
7,998
|
16,631
|
24,629
|
|||||||||
|
Investment advisory fees receivable
|
4,427
|
(33
|
)
|
4,394
|
||||||||
|
Other assets
|
24,551
|
471
|
25,022
|
|||||||||
|
Total assets
|
$
|
895,939
|
$
|
58,494
|
$
|
954,433
|
||||||
|
Liabilities and equity
|
||||||||||||
|
Securities sold, not yet purchased
|
$
|
4,631
|
$
|
4,943
|
$
|
9,574
|
||||||
|
Accrued expenses and other liabilities
|
25,060
|
3,751
|
28,811
|
|||||||||
|
Redeemable noncontrolling interests
|
-
|
49,800
|
49,800
|
|||||||||
|
Total equity
|
866,248
|
-
|
866,248
|
|||||||||
|
Total liabilities and equity
|
$
|
895,939
|
$
|
58,494
|
$
|
954,433
|
||||||
|
Three Months Ended March 31, 2019
|
||||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Total revenues
|
$
|
4,817
|
$
|
(165
|
)
|
$
|
4,652
|
|||||
|
Total expenses
|
11,462
|
1,066
|
12,528
|
|||||||||
|
Operating loss
|
(6,645
|
)
|
(1,231
|
)
|
(7,876
|
)
|
||||||
|
Total other income, net
|
35,983
|
2,738
|
38,721
|
|||||||||
|
Income before income taxes
|
29,338
|
1,507
|
30,845
|
|||||||||
|
Income tax expense
|
6,191
|
-
|
6,191
|
|||||||||
|
Net income before NCI
|
23,147
|
1,507
|
24,654
|
|||||||||
|
Net income attributable to noncontrolling interests
|
-
|
1,507
|
1,507
|
|||||||||
|
Net income
|
$
|
23,147
|
$
|
-
|
$
|
23,147
|
||||||
|
Three Months Ended March 31, 2018
|
||||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Total revenues
|
$
|
4,720
|
$
|
(17
|
)
|
$
|
4,703
|
|||||
|
Total expenses
|
8,441
|
512
|
8,953
|
|||||||||
|
Operating loss
|
(3,721
|
)
|
(529
|
)
|
(4,250
|
)
|
||||||
|
Total other income/(expense), net
|
(25,242
|
)
|
386
|
(24,856
|
)
|
|||||||
|
Loss before income taxes
|
(28,963
|
)
|
(143
|
)
|
(29,106
|
)
|
||||||
|
Income tax benefit
|
(6,734
|
)
|
-
|
(6,734
|
)
|
|||||||
|
Net loss before NCI
|
(22,229
|
)
|
(143
|
)
|
(22,372
|
)
|
||||||
|
Net loss attributable to noncontrolling interests
|
-
|
(143
|
)
|
(143
|
)
|
|||||||
|
Net loss
|
$
|
(22,229
|
)
|
$
|
-
|
$
|
(22,229
|
)
|
||||
|
March 31,
2019
|
December 31,
2018
|
|||||||
|
Cash and cash equivalents
|
$
|
2,561
|
$
|
2,560
|
||||
|
Investments in securities
|
8,538
|
7,253
|
||||||
|
Receivable from brokers
|
(5
|
)
|
553
|
|||||
|
Other assets
|
1
|
(11
|
)
|
|||||
|
Accrued expenses and other liabilities
|
(291
|
)
|
(31
|
)
|
||||
|
Redeemable noncontrolling interests
|
(424
|
)
|
(419
|
)
|
||||
|
AC Group’s net interests in consolidated VIE
|
$
|
10,380
|
$
|
9,905
|
||||
|
E.
|
Fair Value
|
|
March 31, 2019
|
||||||||||||||||||||||||
|
Assets
|
Quoted Prices in Active
Markets for Identical
|
Significant Other
Observable
|
Significant
Unobservable
|
Investments
Using NAV as
|
Other Assets
Not Held at
|
Total
|
||||||||||||||||||
|
Cash equivalents
|
$
|
394,490
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
394,490
|
||||||||||||
|
Investments in partnerships
|
-
|
-
|
-
|
121,753
|
4,386
|
126,139
|
||||||||||||||||||
|
Investments in securities (including GBL stock):
|
||||||||||||||||||||||||
|
Gov’t obligations
|
28,648
|
-
|
-
|
-
|
-
|
28,648
|
||||||||||||||||||
|
Common stocks
|
240,131
|
7,321
|
33
|
-
|
-
|
247,485
|
||||||||||||||||||
|
Mutual funds
|
1,332
|
-
|
-
|
-
|
-
|
1,332
|
||||||||||||||||||
|
Other
|
21
|
145
|
3,311
|
-
|
-
|
3,477
|
||||||||||||||||||
|
Total investments in securities
|
270,132
|
7,466
|
3,344
|
-
|
-
|
280,942
|
||||||||||||||||||
|
Investments in affiliated registered investment companies:
|
||||||||||||||||||||||||
|
Closed-end funds
|
93,434
|
-
|
-
|
-
|
-
|
93,434
|
||||||||||||||||||
|
Mutual funds
|
57,129
|
-
|
-
|
-
|
-
|
57,129
|
||||||||||||||||||
|
Total investments in affiliated
registered investment companies
|
150,563
|
-
|
-
|
-
|
-
|
150,563
|
||||||||||||||||||
|
Total investments
|
420,695
|
7,466
|
3,344
|
121,753
|
4,386
|
557,644
|
||||||||||||||||||
|
Total assets at fair value
|
$
|
815,185
|
$
|
7,466
|
$
|
3,344
|
$
|
121,753
|
$
|
4,386
|
$
|
952,134
|
||||||||||||
|
Liabilities
|
||||||||||||||||||||||||
|
Common stocks
|
$
|
17,011
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
17,011
|
||||||||||||
|
Other
|
-
|
107
|
-
|
-
|
-
|
107
|
||||||||||||||||||
|
Securities sold, not yet purchased
|
$
|
17,011
|
$
|
107
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
17,118
|
||||||||||||
|
December 31, 2018
|
||||||||||||||||||||||||
|
Assets
|
Quoted Prices in Active
Markets for Identical
|
Significant Other
Observable
|
Significant
Unobservable
Inputs (Level 3)
|
Investments
Using NAV as
|
Other Assets
Not Held at
|
Total
|
||||||||||||||||||
|
Cash equivalents
|
$
|
407,239
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
407,239
|
||||||||||||
|
Investments in partnerships
|
-
|
-
|
-
|
114,449
|
4,280
|
118,729
|
||||||||||||||||||
|
Investments in securities (including GBL stock):
|
||||||||||||||||||||||||
|
Gov’t obligations
|
11,707
|
-
|
-
|
-
|
-
|
11,707
|
||||||||||||||||||
|
Common stocks
|
205,978
|
7,161
|
12
|
-
|
-
|
213,151
|
||||||||||||||||||
|
Mutual funds
|
1,161
|
-
|
-
|
-
|
-
|
1,161
|
||||||||||||||||||
|
Other
|
19
|
464
|
3,458
|
-
|
-
|
3,941
|
||||||||||||||||||
|
Total investments in securities
|
218,865
|
7,625
|
3,470
|
-
|
-
|
229,960
|
||||||||||||||||||
|
Investments in affiliated registered investment companies:
|
||||||||||||||||||||||||
|
Closed-end funds
|
85,090
|
-
|
-
|
-
|
-
|
85,090
|
||||||||||||||||||
|
Mutual funds
|
57,045
|
-
|
-
|
-
|
-
|
57,045
|
||||||||||||||||||
|
Total investments in affiliated
registered investment companies
|
142,135
|
-
|
-
|
-
|
-
|
142,135
|
||||||||||||||||||
|
Total investments
|
361,000
|
7,625
|
3,470
|
114,449
|
4,280
|
490,824
|
||||||||||||||||||
|
Total assets at fair value
|
$
|
768,239
|
$
|
7,625
|
$
|
3,470
|
$
|
114,449
|
$
|
4,280
|
$
|
898,063
|
||||||||||||
|
Liabilities
|
||||||||||||||||||||||||
|
Common stocks
|
$
|
9,485
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
9,485
|
||||||||||||
|
Other
|
-
|
89
|
-
|
-
|
-
|
89
|
||||||||||||||||||
|
Securities sold, not yet purchased
|
$
|
9,485
|
$
|
89
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
9,574
|
||||||||||||
|
|
(a) |
Amounts include certain equity method investments in Investment Partnerships which qualify for investment company specialized accounting. These Investment Partnerships
account for their financial assets and liabilities using fair value measures and, therefore, the Company’s investment approximates fair value. At March 31, 2019 and December 31, 2018, investments in these Investment Partnerships were
$111,940 and $105,020, respectively. In addition, certain investments in Investment Partnerships were held by a consolidated entity. At March 31, 2019 and December 31, 2018, these amounts were $9,813 and $9,429, respectively. None of
these investments have been classified in the fair value hierarchy.
|
|
|
(b) |
Amounts include certain equity method investments which are not accounted for under a fair value measure. In accordance with GAAP, certain equity method investees do not
account for both their financial assets and liabilities under fair value measures; therefore, the Company’s investment in such equity method investees may not represent fair value.
|
|
Three months ended March 31, 2019
|
Three months ended March 31, 2018
|
|||||||||||||||||||||||
|
Common
Stocks
|
Other
|
Total
|
Common
Stocks
|
Other
|
Total
|
|||||||||||||||||||
|
Beginning balance
|
$
|
12
|
$
|
3,458
|
$
|
3,470
|
$
|
618
|
$
|
1,169
|
$
|
1,787
|
||||||||||||
|
Consolidated fund
|
-
|
-
|
-
|
-
|
984
|
984
|
||||||||||||||||||
|
Total gains/(losses)
|
(42
|
)
|
(147
|
)
|
(189
|
)
|
(11
|
)
|
8
|
(3
|
)
|
|||||||||||||
|
Purchases
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||
|
Sales
|
-
|
-
|
-
|
-
|
(21
|
)
|
(21
|
)
|
||||||||||||||||
|
Transfers
|
63
|
-
|
63
|
-
|
-
|
-
|
||||||||||||||||||
|
Ending balance
|
$
|
33
|
$
|
3,311
|
$
|
3,344
|
$
|
607
|
$
|
2,140
|
$
|
2,747
|
||||||||||||
|
Changes in net unrealized gain/(loss) included in Net gain/(loss) from investments related to level 3 assets
still held as of the reporting date
|
$
|
(42
|
)
|
$
|
(147
|
)
|
$
|
(189
|
)
|
$
|
(11
|
)
|
$
|
-
|
$
|
(11
|
)
|
|||||||
|
F.
|
Income Taxes
|
|
G.
|
Earnings Per Share
|
|
Three Months Ended March 31,
|
||||||||
|
(amounts in thousands, except per share amounts)
|
2019
|
2018
|
||||||
|
Basic:
|
||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
23,147
|
$
|
(22,229
|
)
|
|||
|
Weighted average shares outstanding
|
22,584
|
23,508
|
||||||
|
Basic net income/(loss) attributable to Associated Capital Group, Inc.’s
shareholders per share
|
$
|
1.02
|
$
|
(0.95
|
)
|
|||
|
Diluted:
|
||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
23,147
|
$
|
(22,229
|
)
|
|||
|
Weighted average share outstanding
|
22,584
|
23,508
|
||||||
|
Dilutive restricted stock awards
|
-
|
-
|
||||||
|
Total
|
22,584
|
23,508
|
||||||
|
Diluted net income/(loss) attributable to Associated Capital Group, Inc.’s
shareholders per share
|
$
|
1.02
|
$
|
(0.95
|
)
|
|||
|
H.
|
Stockholders’ Equity
|
|
I.
|
Goodwill and Identifiable Intangible Assets
|
|
J.
|
Commitments and Contingencies
|
|
K.
|
Subsequent Events
|
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (INCLUDING QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK) (“MD&A”)
|
|
(in thousands, except per share data)
|
Three months ended March 31,
|
|||||||
|
2019
|
2018
|
|||||||
|
Revenues
|
||||||||
|
Investment advisory and incentive fees
|
$
|
2,733
|
$
|
2,529
|
||||
|
Institutional research services
|
1,913
|
2,152
|
||||||
|
Other
|
6
|
22
|
||||||
|
Total revenues
|
4,652
|
4,703
|
||||||
|
Expenses
|
||||||||
|
Compensation
|
5,896
|
6,324
|
||||||
|
Stock-based compensation
|
415
|
72
|
||||||
|
Management fee
|
3,260
|
-
|
||||||
|
Other operating expenses
|
2,957
|
2,557
|
||||||
|
Total expenses
|
12,528
|
8,953
|
||||||
|
Operating loss
|
(7,876
|
)
|
(4,250
|
)
|
||||
|
Other income/(expense)
|
||||||||
|
Net gain/(loss) from investments
|
34,979
|
(27,530
|
)
|
|||||
|
Interest and dividend income
|
3,786
|
2,707
|
||||||
|
Interest expense
|
(44
|
)
|
(33
|
)
|
||||
|
Total other income/(expense), net
|
38,721
|
(24,856
|
)
|
|||||
|
Income/(loss) before income taxes
|
30,845
|
(29,106
|
)
|
|||||
|
Income tax expense/(benefit)
|
6,191
|
(6,734
|
)
|
|||||
|
Net income/(loss)
|
24,654
|
(22,372
|
)
|
|||||
|
Net income/(loss) attributable to noncontrolling interests
|
1,507
|
(143
|
)
|
|||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
23,147
|
$
|
(22,229
|
)
|
|||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders per share:
|
||||||||
|
Basic
|
$
|
1.02
|
$
|
(0.95
|
)
|
|||
|
Diluted
|
1.02
|
(0.95
|
)
|
|||||
|
|
|
|
% Change From
|
|||||||||||||||||
|
March 31,
2019
|
December 31,
2018
|
March 31,
2018
|
December 31,
2018
|
March 31,
2018
|
||||||||||||||||
|
Event Merger Arbitrage
|
$
|
1,401
|
$
|
1,342
|
$
|
1,407
|
4.4
|
(0.4
|
)
|
|||||||||||
|
Event-Driven Value
|
127
|
118
|
88
|
7.6
|
44.3
|
|||||||||||||||
|
Other
|
63
|
60
|
65
|
5.0
|
(3.1
|
)
|
||||||||||||||
|
Total AUM
|
$
|
1,591
|
$
|
1,520
|
$
|
1,560
|
4.7
|
2.0
|
||||||||||||
|
December 31,
2018
|
Market
appreciation/
|
Net cash
flows
|
March 31,
2019
|
|||||||||||||
|
Event Merger Arbitrage
|
$
|
1,342
|
$
|
27
|
$
|
32
|
$
|
1,401
|
||||||||
|
Event-Driven Value
|
118
|
5
|
4
|
127
|
||||||||||||
|
Other
|
60
|
4
|
(1
|
)
|
63
|
|||||||||||
|
Total AUM
|
$
|
1,520
|
$
|
36
|
$
|
35
|
$
|
1,591
|
||||||||
|
Three months ended March 31,
|
||||||||
|
2019
|
2018
|
|||||||
|
Cash flows provided by (used in):
|
||||||||
|
Operating activities
|
$
|
(12,705
|
)
|
$
|
(29,388
|
)
|
||
|
Investing activities
|
2,337
|
15,000
|
||||||
|
Financing activities
|
(3,176
|
)
|
5,201
|
|||||
|
Net decrease
|
(13,544
|
)
|
(9,187
|
)
|
||||
|
Cash and cash equivalents at beginning of period
|
409,564
|
293,112
|
||||||
|
Increase in cash from consolidation
|
-
|
47
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
396,020
|
$
|
283,972
|
||||
|
|
• |
the adverse effect from a decline in the securities markets
|
|
|
• |
a decline in the performance of our products
|
|
|
• |
a general downturn in the economy
|
|
|
• |
changes in government policy or regulation
|
|
|
• |
changes in our ability to attract or retain key employees
|
|
|
• |
unforeseen costs and other effects related to legal proceedings or investigations of governmental and self-regulatory organizations
|
|
Period
|
Total
Number of
Shares
Repurchased
|
Average
Price Paid Per
Share, net of
Commissions
|
Total Number of
Shares Repurchased as
Part of Publicly
Announced Plans
or Programs
|
Maximum
Number of Shares
That May Yet Be
Purchased Under
the Plans or Programs
|
||||||||||||
|
01/01/19 - 01/31/19
|
-
|
$
|
-
|
-
|
1,204,213
|
|||||||||||
|
02/01/19 - 02/28/19
|
-
|
-
|
-
|
1,204,213
|
||||||||||||
|
03/01/19 - 03/31/19
|
9,776
|
40.03
|
9,776
|
1,194,437
|
||||||||||||
|
Totals
|
9,776
|
$
|
40.03
|
9,776
|
||||||||||||
|
Certification of CEO pursuant to Rule 13a-14(a).
|
|
|
Certification of CAO pursuant to Rule 13a-14(a).
|
|
|
Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certification of CAO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
|
|
|
101.INS
|
XBRL Instance Document
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
ASSOCIATED CAPITAL GROUP, INC.
|
|
|
(Registrant)
|
|
|
|
|
|
By: /s/ Kenneth D. Masiello
|
|
|
Name: Kenneth D. Masiello
|
|
|
Title: Chief Accounting Officer
|
|
|
Date: May 8, 2019
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|